A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the drug elacestrant after a U-turn by the National Institute for Health ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

The NHS is set to introduce a new once-a-day tablet that targets advanced breast cancer, with around 1,100 patients in England expected to benefit from the treatment. The National Institute for ...

A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in England set to benefit. The final guidance on elacestrant by the National ...

A consultant analysing a mammogram of a woman’s breast (Rui Vieira/PA) A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in ...

A new once-a-day tablet that treats advanced breast cancer is to be rolled out on the NHS, with about 1,100 patients in England set to benefit. The final guidance on elacestrant by the National ...

Ranchi: Jharkhand health minister Irfan Ansari on Tuesday announced that 42,000 sahiyas (community health workers) will ...

Pain is one of the most common symptoms associated with cancer. It causes much concern to patients and their family members. Despite the existence of well known guidelines for cancer pain ...

The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for management of moderate to severe cancer pain. Few data about the efficacy of OCRT and clinical outcomes ...